Skip to content

Corruption Ledger

The Public Ledger of Corruption

  • About
  • Corruption
    • banks
    • corporate
    • environment
    • government
    • health
    • Leaks
    • misinformation
    • privacy and surveillance
    • Protest and Unrest
  • Sanctions
    • Sanctions News
    • Global Sanctions Feed
    • European Sanctions Feed
    • Canadian Sanctions Feed
    • US Sanctions Feed
  • Regions
    • Asias
    • Europe
    • Middle East
    • Oceania
    • US & Canada
    • World
  • Enforcement
  • Economy
  • International Conflict
  • Tech
  • Cryptocurrency
  • Free Speech
  • Toggle search form
  • Wells Fargo fined for sanctions breach _enforcement
  • Google Co-Founder, Other Billionaires Are Issued Subpoenas in Lawsuit Over JPMorgan’s Ties to Jeffrey Epstein; Sergey Brin, Thomas Pritzker, Mortimer Zuckerman and Michael Ovitz are asked for information in U.S. Virgin Islands’ civil suit against bank All Regions
  • Chinese businessman Guo Wengui seeks bail in $1 billion fraud case All Regions
  • IMF approves $15.6 billion Ukraine loan, part of $115 billion in global support All Regions
  • Russian preventive strike ‘petition’ possible after Ukrainian nuke plea -ITAR-TASS All Regions
  • Dominion’s Fox News defamation case headed to trial All Regions
  • Pussy Riot Member Accused of ‘Insulting Religious Sensibilities’, adds her to wanted list All Regions
  • Finland Clears Last Obstacle to NATO Entry All Regions

Opioid manufacturer Purdue Pharma: Criminal and Civil Investigations

Posted on October 21, 2020February 20, 2023 By CorruptionLedger No Comments on Opioid manufacturer Purdue Pharma: Criminal and Civil Investigations

Today, the Department of Justice announced a global resolution of its criminal and civil investigations into the opioid manufacturer Purdue Pharma LP (Purdue), and a civil resolution of its civil investigation into individual shareholders from the Sackler family.  The resolutions with Purdue are subject to the approval of the bankruptcy court.

“The abuse and diversion of prescription opioids has contributed to a national tragedy of addiction and deaths, in addition to those caused by illicit street opioids,” said Deputy Attorney General Jeffrey A. Rosen.  “With criminal guilty pleas, a federal settlement of more than $8 billion, and the dissolution of a company and repurposing its assets entirely for the public’s benefit, the resolution in today’s announcement re-affirms that the Department of Justice will not relent in its multi-pronged efforts to combat the opioids crisis.”

“Today’s resolution is the result of years of hard work by the FBI and its partners to combat the opioid crisis in the U.S.,” said Steven M. D’Antuono, Assistant Director in Charge of the FBI Washington Field Office.  “Purdue, through greed and violation of the law, prioritized money over the health and well-being of patients.  The FBI remains committed to holding companies accountable for their illegal and inexcusable activity and to seeking justice, on behalf of the victims, for those who contributed to the opioid crisis.”

“The opioid epidemic remains a significant public health challenge that impacts the lives of men and women across the country,” said Gary L. Cantrell Deputy Inspector General for Investigations at the U.S. Department of Health and Human Services’ Office of Inspector General.  “Unfortunately, Purdue’s reckless actions and violation of the law senselessly risked patients’ health and well-being.  With our law enforcement partners, we will continue to combat the opioid crisis, including holding the pharmaceutical industry and its executives accountable.”

“This resolution closes a particularly sad chapter in the ongoing battle against opioid addiction,” said Drug Enforcement Administration (DEA) Assistant Administrator Tim McDermott.  “Purdue Pharma actively thwarted the United States’ efforts to ensure compliance and prevent diversion.  The devastating ripple effect of Purdue’s actions left lives lost and others addicted.  DEA will continue to work tirelessly with our partners and the pharmaceutical industry to address the damage that has been done, and bring an end to this epidemic that has gripped the nation for far too long.”

Purdue Pharma has agreed to plead guilty in federal court in New Jersey to a three-count felony information charging it with one count of dual-object conspiracy to defraud the United States and to violate the Food, Drug, and Cosmetic Act, and two counts of conspiracy to violate the Federal Anti-Kickback Statute.  The criminal resolution includes the largest penalties ever levied against a pharmaceutical manufacturer, including a criminal fine of $3.544 billion and an additional $2 billion in criminal forfeiture.  For the $2 billion forfeiture, the company will pay $225 million on the effective date of the bankruptcy, and, as further explained below, the department is willing to credit the value conferred by the company to State and local governments under the department’s anti-piling on and coordination policy.  Purdue has also agreed to a civil settlement in the amount of $2.8 billion to resolve its civil liability under the False Claims Act.  Separately, the Sackler family has agreed to pay $225 million in damages to resolve its civil False Claims Act liability.

The resolutions do not include the criminal release of any individuals, including members of the Sackler family, nor are any of the company’s executives or employees receiving civil releases.

While the global resolution with the company is subject to approval by the bankruptcy court in the Southern District of New York, one important condition in the resolution is that the company would cease to operate in its current form and would instead emerge from bankruptcy as a public benefit company (PBC) owned by a trust or similar entity designed for the benefit of the American public, to function entirely in the public interest.  Indeed, not only will the PBC endeavor to deliver legitimate prescription drugs in a manner as safe as possible, but it will aim to donate, or provide steep discounts for, life-saving overdose rescue drugs and medically assisted treatment medications to communities, and the proceeds of the trust will be directed toward State and local opioid abatement programs.  Based on the value that would be conferred to State and local governments through the PBC, the department is willing to credit up to $1.775 billion against the agreed $2 billion forfeiture amount.  The department looks forward to working with the creditor groups in the bankruptcy in charting the path forward for this PBC so that its public health goals can be best accomplished.

The Criminal Pleas

As part of the plea, Purdue will admit that from May 2007 through at least March 2017, Purdue conspired to defraud the United States by impeding the lawful function of the DEA by representing to the DEA that Purdue maintained an effective anti-diversion program when, in fact, Purdue continued to market its opioid products to more than 100 health care providers whom the company had good reason to believe were diverting opioids and by reporting misleading information to the DEA to boost Purdue’s manufacturing quotas.  The misleading information comprised prescription data that included prescriptions written by doctors that Purdue had good reason to believe were engaged in diversion.  The conspiracy also involved aiding and abetting violations of the Food, Drug, and Cosmetic Act by facilitating the dispensing of its opioid products, including OxyContin, without a legitimate medical purpose, and thus without lawful prescriptions.

In addition, Purdue will admit to conspiring to violate the Federal Anti-Kickback Statute.  Between June 2009 and March 2017, Purdue made payments to two doctors through Purdue’s doctor speaker program to induce those doctors to write more prescriptions of Purdue’s opioid products.  Similarly, from approximately April 2016 through December 2016, Purdue made payments to Practice Fusion Inc., an electronic health records company, in exchange for referring, recommending, and arranging for the ordering of Purdue’s extended release opioid products – OxyContin, Butrans, and Hysingla.

The Civil Settlements

The department’s civil settlements resolve the United States’ claims as to both Purdue and its individual shareholders, members of the Sackler family.

The civil settlement with Purdue provides the United States with an allowed, unsubordinated, general unsecured bankruptcy claim for recovery of $2.8 billion.   This settlement resolves allegations that from 2010 to 2018, Purdue caused false claims to be submitted to federal health care programs, specifically Medicare, Medicaid, TRICARE, the Federal Employees Health Benefits Program, and the Indian Health Service.  The government alleged that Purdue promoted its opioid drugs to health care providers it knew were prescribing opioids for uses that were unsafe, ineffective, and medically unnecessary, and that often led to abuse and diversion.  For example, Purdue learned that one doctor was known by patients as “the Candyman” and was prescribing “crazy dosing of OxyContin,” yet Purdue had sales representatives meet with the doctor more than 300 times.  It also resolves the government’s allegations that Purdue engaged in three different kickback schemes to induce prescriptions of its opioids.  First, Purdue paid certain doctors ostensibly to provide educational talks to other health care professionals and serve as consultants, but in reality to induce them to prescribe more OxyContin.  Second, Purdue paid kickbacks to Practice Fusion, as described above.  Third, Purdue entered into contracts with certain specialty pharmacies to fill prescriptions for Purdue’s opioid drugs that other pharmacies had rejected as potentially lacking medical necessity.

Under a separate civil settlement, individual members of the Sackler family will pay the United States $225 million arising from the alleged conduct of Dr. Richard Sackler, David Sackler, Mortimer D.A. Sackler, Dr. Kathe Sackler, and Jonathan Sackler (the Named Sacklers).  This settlement resolves allegations that, in 2012, the Named Sacklers knew that the legitimate market for Purdue’s opioids had contracted.  Nevertheless, they requested that Purdue executives recapture lost sales and increase Purdue’s share of the opioid market.  The Named Sacklers then approved a new marketing program beginning in 2013 called “Evolve to Excellence,” through which Purdue sales representatives intensified their marketing of OxyContin to extreme, high-volume prescribers who were already writing “25 times as many OxyContin scripts” as their peers, causing health care providers to prescribe opioids for uses that were unsafe, ineffective, and medically unnecessary, and that often led to abuse and diversion.

The civil settlement also resolves the government’s allegations that from approximately 2008 to 2018, at the Named Sacklers’ request, Purdue transferred assets into Sackler family holding companies and trusts that were made to hinder future creditors, and/or were otherwise voidable as fraudulent transfers.

Today’s resolution does not resolve claims that states may have against Purdue or members of the Sackler family, nor does it impede the debtors’ ability to recover any fraudulent transfers.

Today’s announcement was made by Deputy Attorney General Jeffrey A. Rosen; Acting Assistant Attorney General of the Civil Division Jeffrey Clark; U.S. Attorney for the District of Vermont Christina Nolan; and First Assistant U.S. Attorney for the District of New Jersey Rachael Honig.  The criminal investigation was conducted by the U.S. Attorney’s Offices for the Districts of New Jersey and Vermont, the Consumer Protection Branch of the Department of Justice’s Civil Division, and the FBI’s Washington, D.C. and Newark Field Offices, with assistance by the DEA and the U.S. Attorney’s Office for the Northern District of Ohio.  The civil settlements were handled by the Fraud Section of the Commercial Litigation Branch of the Department of Justice’s Civil Division, and the U.S. Attorney’s Offices for the Districts of New Jersey and Vermont, with assistance from the Department of Health and Human Services, Office of General Counsel and Office of Counsel to the Inspector General; the Defense Health Agency; and the Office of Personnel Management.  The Purdue bankruptcy matter is being handled by the U.S. Attorney’s Office for the Southern District of New York and the Civil Division’s Commercial Litigation Branch, Corporate/Finance Section.

Except to the extent of Purdue’s admissions as part of its criminal resolution, the claims resolved by the civil settlements are allegations only.  There has been no determination of liability in the civil matters.

https://www.fbi.gov/news/press-releases/justice-department-announces-global-resolution-of-criminal-and-civil-investigations-with-opioid-manufacturer-purdue-pharma-and-civil-settlement-with-members-of-the-sackler-family

corporate corruption, Corruption, government corruption, health, Region US & Canada Tags:Purdue Pharma

Post navigation

Previous Post: Ukrainian Trust in Authorities Decreases
Next Post: Ukraine’s Constitutional Crisis

See also

  • Owners of sanctioned Russian bank to offload stakes – FT All Regions
  • Spain: Rights experts call for probe into claim Catalan leaders were spied on All Regions
  • NATO chief: NATO Membership for Finland, Sweden ‘top priority’ All Regions
  • Ukraine’s Constitutional Crisis All Regions
  • Credit Suisse, UBS facing US Russia-sanctions probe, subpoenas also sent to employees major US banks _enforcement
  • Blackstone Group company employed children employed children to clean slaughterhouses in U.S. (Packers Sanitation Services / PSSI) All Regions

You must log in to post a comment.

  • Wells Fargo fined for sanctions breach
  • Google Co-Founder, Other Billionaires Are Issued Subpoenas in Lawsuit Over JPMorgan’s Ties to Jeffrey Epstein; Sergey Brin, Thomas Pritzker, Mortimer Zuckerman and Michael Ovitz are asked for information in U.S. Virgin Islands’ civil suit against bank
  • Chinese businessman Guo Wengui seeks bail in $1 billion fraud case
  • IMF approves $15.6 billion Ukraine loan, part of $115 billion in global support
  • Dominion’s Fox News defamation case headed to trial
  • Pussy Riot Member Accused of ‘Insulting Religious Sensibilities’, adds her to wanted list
  • Russian preventive strike ‘petition’ possible after Ukrainian nuke plea -ITAR-TASS
  • Finland Clears Last Obstacle to NATO Entry
  • Macron announces water saving plan; says protests will not stop reforms
  • Kremlin comments on WSJ correspondent arrest
  • Minnesota derailment spills ethanol, prompts evacuations
  • Deutsche Bank Stock Tumbles On Contagion Fears
  • Wall St falls as bank contagion fears flare up
  • US due diligence firm Mintz Group says staff detained in China after office raid
  • Credit Suisse, UBS facing US Russia-sanctions probe, subpoenas also sent to employees major US banks
  • (US) Appeals court sides with Justice Department in Trump lawyer fight
  • Russia boosts defenses near Japan; accuses U.S. of expanding Asia-Pacific presence
  • US credit card debt at record high as Fed raises rates again
  • Russian tech giants appeal Nasdaq delisting
  • China Denounces Submarine Deal
  • China insists it is impartial on Russia-Ukraine, questions US ‘pouring weapons into the conflict’
  • German ambassador confirms that Putin would be arrested if he entered Germany
  • Danish Navy present near Nord Stream 2 – media
  • Railroad reluctant to say who OK’d chemical burn after Ohio derailment
  • Scientists insist on continuing search for toxics in East Palestine
  • Top aide of Canadian PM Trudeau will testify in parliament on Chinese election meddling
  • Zuckerberg, Meta sued for failing to address sex trafficking, child exploitation
  • Norfolk Southern: Independent group finds toxic chemicals that Ohio EPA didn’t – Ohio train derailment (East Palestine)
  • JP Morgan, Deutsche Bank to face lawsuit over Epstein ties
  • Putin announces readiness to switch to the Chinese Yuan currency in foreign trade
  • Putin and Xi sign two documents in Moscow
  • Russia says jet scrambled as US B-52 bombers fly over Baltic Sea
  • Paris police, protesters clash for third night over Macron’s pension reform
  • Global / ChipMixer software ‘taken down’ by multi-national law enforcement coalition
  • Russian officials scoff at ICC’s indictment of Putin
  • SVB parent company files for bankruptcy
  • Violent protests in France over Macron’s retirement age push
  • International court issues war crimes warrant for Putin
  • US / Chinese tycoon and Bannon ally Guo Wengui charged with $1bn fraud
  • Samsung to invest $230 billion to build mega chip cluster
  • Pentagon calls Moscow over drone incident
  • Credit Suisse slump renews fears of global banking crisis
  • Silicon Valley Bank execs, parent company sued after collapse
  • Credit Suisse Shares Plunge as Bank Storm Spreads to Europe
  • Dow tumbles nearly 500 points as Credit Suisse stokes fears of bank failure contagion
  • Russian jet, US drone crash over Black Sea, US military says
  • Dark hours for Credit Suisse Bank
  • Account full of holes at Credit Suisse
  • Russia blasts Canada over ‘regime change’
  • US / Sterling Bancorp, Inc. to Plead Guilty to $69M Securities Fraud
  • US drones have no business near Russia – ambassador
  • Inflation in Argentina surges past 100 percent in historic spike
  • Paris visitors alarmed at trash strike
  • China says AUKUS on ‘dangerous path’ with nuclear subs deal
  • Taiwan unveils portable attack drone as China tensions rise
  • Putin rejects theory about Ukrainian role in pipeline blasts
  • Syrian president Assad arrives in Moscow, set to meet Putin
  • Marin’s F-18 proposal fizzles, as a new Finnish NATO tack emerges
  • Ohio sues Norfolk Southern over toxic train derailment
  • US / ‘Forever chemicals’ in drinking water
  • Nord Stream blasts staged by a state-level actor – Putin
  • No Harvey Weinstein retrial on rape, sex assault charges
  • US / Silicon Valley Bank execs, parent company sued after collapse
  • As U.S. steps back from Middle East, China steps in
  • Western sanctions shielding Russian financial system from global crisis – Kremlin
  • Moody’s puts US banks on notice
  • Robert Kiyosaki predicts next big bank to fold
  • UK $6 billion defense boost targets atomic submarines, weapons top-up
  • BBC gets £20 million boost from UK govt
  • Document reveals why Canada arms Saudi Arabia – media
  • Taiwan braces for ‘total blockade’ – media
  • Biden administration lets Ukrainians who fled war stay in US
  • Ratings Deceit: S&P sued for deceitful CDO ratings
Rumble Video

Corruption Ledger Follow

The Public ▇▇▇ Ledger of ▇▇▇ Corruption. https://t.co/wkobrEotQR

5amResearch
Corruption Ledger @5amresearch ·
10 Feb

News Coverage of the September 2022 #NordStream Pipeline Attack https://corruptionledger.com/news-coverage-of-the-september-2022-nord-stream-pipeline-attack/ via @5amResearch

Reply on Twitter 1623868066818928641 Retweet on Twitter 1623868066818928641 Like on Twitter 1623868066818928641
Corruption Ledger @5amresearch ·
10 Feb

Mia Jankowicz of Business Insider calls Pulitzer prize-winning journalist Seymore Harsh a "discredited journalist." #NordStream

Reply on Twitter 1623857264086974464 Retweet on Twitter 1623857264086974464 Like on Twitter 1623857264086974464 1
Corruption Ledger @5amresearch ·
9 Feb

#Kraken to Discontinue Unregistered Offer and Sale of Crypto Asset Staking-As-A-Service Program and Pay $30 Million to Settle SEC Charges
https://www.sec.gov/news/press-release/2023-25

Reply on Twitter 1623815305452560384 Retweet on Twitter 1623815305452560384 Like on Twitter 1623815305452560384
Corruption Ledger @5amresearch ·
9 Feb

SpaceX: Ukraine breaching agreement, weaponizing Starlink https://en.mdn.tv/71FW

Reply on Twitter 1623685510496505860 Retweet on Twitter 1623685510496505860 Like on Twitter 1623685510496505860
Load More

–

  • Register
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Copyright © 2022 Corruption Ledger. This web site contains no ads.